NK Cells in Myeloproliferative Neoplasms (MPN)
Myeloproliferative neoplasms (MPNs) comprise a heterogenous group of hematologic neoplasms which are divided into Philadelphia positive (Ph+), and Philadelphia negative (Ph−) or classical MPNs. A variety of immunological factors including inflammatory, as well as immunomodulatory processes, closely...
Main Authors: | Erin Naismith, Janine Steichen, Sieghart Sopper, Dominik Wolf |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/17/4400 |
Similar Items
-
New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options
by: Domenico Penna
Published: (2021-10-01) -
Pediatric Philadelphia-Negative Myeloproliferative Neoplasms in the Era of WHO Classification: A Systematic Review
by: Abdulrahman F. Al-Mashdali, et al.
Published: (2023-01-01) -
Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs
by: Angela Liu, et al.
Published: (2022-12-01) -
Risks of Solid and Lymphoid Malignancies in Patients with Myeloproliferative Neoplasms: Clinical Implications
by: Mette Brabrand, et al.
Published: (2020-10-01) -
Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan
by: Yoko Edahiro, et al.
Published: (2024-12-01)